Skip to content

Released Aug 8, 2016, after the close

10-Q filed Aug 9, 2016, 40 days after period end · 0001162194-16-000224

Q2 2016 · 10-Q
Revenue$28.17M−1.6% vs Q2 2015−2.9% vs Q1 2016
Net Income-$18.62MN/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.64N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$18,142,000N/M
Operating Cash Flowderived-$7,354,000N/M
Free Cash Flowderived-$8,872,000N/M
Margins · derived
Operating margin-64.4%−13.2 pt vs Q2 2015
Net margin-66.1%−12.9 pt vs Q2 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2016Q2 2015Q2 2014Q2 2013
Revenue$28.17M$28.62M$27.61M$17.48M
Net Income-$18.62M-$15.24M-$12.68M-$4.05M
EPS Diluted-$0.64-$0.53-$0.45-$0.16

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR